Clinical Trial Update: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 pharmacodynamic study of sitagliptin is planned for patients with progressive grade 4 gliomas, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioblastoma

Drugs mentioned

• Januvia (sitagliptin) (sitagliptin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma, Brain Tumor | Phase 2 | Status: RECRUITING